The University of Southampton
University of Southampton Institutional Repository

Detailed characterization of a long-term rodent model of critical illness and recovery

Detailed characterization of a long-term rodent model of critical illness and recovery
Detailed characterization of a long-term rodent model of critical illness and recovery

Objective: to characterize a long-term model of recovery from critical illness, with particular emphasis on cardiorespiratory, metabolic, and muscle function.

Design: randomized controlled animal study.

Setting: university research laboratory.

Subject: male Wistar rats.

Interventions: intraperitoneal injection of the fungal cell wall constituent, zymosan or n-saline.

Measurements and main results: following intervention, rats were followed for up to 2 weeks. Animals with zymosan peritonitis reached a clinical and biochemical nadir on day 2. Initial reductions were seen in body weight, total body protein and fat, and muscle mass. Leg muscle fiber diameter remained subnormal at 14 days with evidence of persisting myonecrosis, even though gene expression of regulators of muscle mass (e.g., MAFbx, MURF1, and myostatin) had peaked on days 2-4 but normalized by day 7. Treadmill exercise capacity, forelimb grip strength, and in vivo maximum tetanic force were also reduced. Food intake was minimal until day 4 but increased thereafter. This did not relate to appetite hormone levels with early (6 hr) rises in plasma insulin and leptin followed by persisting subnormal levels; ghrelin levels did not change. Serum interleukin-6 level peaked at 6 hours but had normalized by day 2, whereas interleukin-10 remained persistently elevated and high-density lipoprotein cholesterol persistently depressed. There was an early myocardial depression and rise in core temperature, yet reduced oxygen consumption and respiratory exchange ratio with a loss of diurnal rhythmicity that showed a gradual but incomplete recovery by day 7.

Coclusions: this detailed physiological, metabolic, hormonal, functional, and histological muscle characterization of a model of critical illness and recovery reproduces many of the findings reported in human critical illness. It can be used to assess putative therapies that may attenuate loss, or enhance recovery, of muscle mass and function.

Animals, Body Weight, Critical Illness, Disease Models, Animal, Energy Intake, Exercise Test, Fats, Hand Strength, Heart Function Tests, Interleukins, Lipids, Male, Muscle, Skeletal, Proteins, Rats, Rats, Wistar, Journal Article, Research Support, Non-U.S. Gov't
0090-3493
e84-96
Hill, Neil E
e1ab5dba-5954-4203-b232-06862b699ce1
Saeed, Saima
bda5ff64-86bf-4da3-8279-1e72b4237991
Phadke, Rahul
ddd1d98b-41ac-456b-bb1b-34a895c30e3b
Ellis, Matthew J
afbca752-ced4-40dd-b0af-d9ecffbd5b63
Chambers, Darren
ff78a735-65b4-4aff-8b89-4308011dcc40
Wilson, Duncan R
b52259d5-bba7-4b27-bff0-f5c262e1f0e9
Castells, Josiane
42684737-6de3-4cdd-b5ee-916ea31858d9
Morel, Jerome
3bf1e92d-4db0-4bd1-8347-3b89ded099eb
Freysennet, Damien G
c73c9985-0074-4120-811e-5865cd454be7
Brett, Stephen J
24863e86-fb61-428d-bac6-b517912145b2
Murphy, Kevin G
9ec0f99e-54c1-48d0-957a-474f790d7b26
Singer, Mervyn
87229716-c753-44ab-a382-3f93c1c5441d
Hill, Neil E
e1ab5dba-5954-4203-b232-06862b699ce1
Saeed, Saima
bda5ff64-86bf-4da3-8279-1e72b4237991
Phadke, Rahul
ddd1d98b-41ac-456b-bb1b-34a895c30e3b
Ellis, Matthew J
afbca752-ced4-40dd-b0af-d9ecffbd5b63
Chambers, Darren
ff78a735-65b4-4aff-8b89-4308011dcc40
Wilson, Duncan R
b52259d5-bba7-4b27-bff0-f5c262e1f0e9
Castells, Josiane
42684737-6de3-4cdd-b5ee-916ea31858d9
Morel, Jerome
3bf1e92d-4db0-4bd1-8347-3b89ded099eb
Freysennet, Damien G
c73c9985-0074-4120-811e-5865cd454be7
Brett, Stephen J
24863e86-fb61-428d-bac6-b517912145b2
Murphy, Kevin G
9ec0f99e-54c1-48d0-957a-474f790d7b26
Singer, Mervyn
87229716-c753-44ab-a382-3f93c1c5441d

Hill, Neil E, Saeed, Saima, Phadke, Rahul, Ellis, Matthew J, Chambers, Darren, Wilson, Duncan R, Castells, Josiane, Morel, Jerome, Freysennet, Damien G, Brett, Stephen J, Murphy, Kevin G and Singer, Mervyn (2015) Detailed characterization of a long-term rodent model of critical illness and recovery. Critical Care Medicine, 43 (3), e84-96. (doi:10.1097/CCM.0000000000000854).

Record type: Article

Abstract

Objective: to characterize a long-term model of recovery from critical illness, with particular emphasis on cardiorespiratory, metabolic, and muscle function.

Design: randomized controlled animal study.

Setting: university research laboratory.

Subject: male Wistar rats.

Interventions: intraperitoneal injection of the fungal cell wall constituent, zymosan or n-saline.

Measurements and main results: following intervention, rats were followed for up to 2 weeks. Animals with zymosan peritonitis reached a clinical and biochemical nadir on day 2. Initial reductions were seen in body weight, total body protein and fat, and muscle mass. Leg muscle fiber diameter remained subnormal at 14 days with evidence of persisting myonecrosis, even though gene expression of regulators of muscle mass (e.g., MAFbx, MURF1, and myostatin) had peaked on days 2-4 but normalized by day 7. Treadmill exercise capacity, forelimb grip strength, and in vivo maximum tetanic force were also reduced. Food intake was minimal until day 4 but increased thereafter. This did not relate to appetite hormone levels with early (6 hr) rises in plasma insulin and leptin followed by persisting subnormal levels; ghrelin levels did not change. Serum interleukin-6 level peaked at 6 hours but had normalized by day 2, whereas interleukin-10 remained persistently elevated and high-density lipoprotein cholesterol persistently depressed. There was an early myocardial depression and rise in core temperature, yet reduced oxygen consumption and respiratory exchange ratio with a loss of diurnal rhythmicity that showed a gradual but incomplete recovery by day 7.

Coclusions: this detailed physiological, metabolic, hormonal, functional, and histological muscle characterization of a model of critical illness and recovery reproduces many of the findings reported in human critical illness. It can be used to assess putative therapies that may attenuate loss, or enhance recovery, of muscle mass and function.

This record has no associated files available for download.

More information

Published date: 1 March 2015
Keywords: Animals, Body Weight, Critical Illness, Disease Models, Animal, Energy Intake, Exercise Test, Fats, Hand Strength, Heart Function Tests, Interleukins, Lipids, Male, Muscle, Skeletal, Proteins, Rats, Rats, Wistar, Journal Article, Research Support, Non-U.S. Gov't

Identifiers

Local EPrints ID: 428106
URI: http://eprints.soton.ac.uk/id/eprint/428106
ISSN: 0090-3493
PURE UUID: 4de1cd33-00c8-4779-8e8a-c93a1a1b1c37

Catalogue record

Date deposited: 11 Feb 2019 17:30
Last modified: 16 Mar 2024 00:09

Export record

Altmetrics

Contributors

Author: Neil E Hill
Author: Saima Saeed
Author: Rahul Phadke
Author: Matthew J Ellis
Author: Darren Chambers
Author: Duncan R Wilson
Author: Josiane Castells
Author: Jerome Morel
Author: Damien G Freysennet
Author: Stephen J Brett
Author: Kevin G Murphy
Author: Mervyn Singer

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×